|
시장보고서
상품코드
2086085
모바일 이미징 서비스 시장 : 이미징 유형별, 서비스 유형별, 최종 사용자별, 용도별, 운영 모드별 예측(2026-2032년)Mobile Imaging Services Market by Imaging Type, Service Type, End User, Application, Mode of Operation - Global Forecast 2026-2032 |
||||||
360iResearch
모바일 이미징 서비스 시장은 2032년까지 연평균 복합 성장률(CAGR) 4.75%로 성장이 전망되며, 46억 9,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 : 2025년 | 33억 9,000만 달러 |
| 추정 연도 : 2026년 | 35억 4,000만 달러 |
| 예측 연도 : 2032년 | 46억 9,000만 달러 |
| CAGR(%) | 4.75% |
모바일 영상 서비스는 병원의 고정된 방사선과 부서를 넘어선 진단 능력이 필요한 의료 시스템에 있어 핵심적인 접근 전략으로 자리 잡고 있습니다. 이 시장에는 밴, 모듈형 유닛, 병상 옆 시스템, 주문형 인력 배치 모델을 통해 제공되는 이동식 X선, 초음파, CT, MRI, 유방촬영술, 투시 검사, 현장 진단 영상 진단이 포함됩니다.
모바일 이미징 서비스의 현황은 일회성 장비 배치에서 통합된 진단 네트워크로 점차 전환되고 있습니다. 의료 제공업체들은 처리 시간을 단축하고, 분산된 의료 거점 전반에 걸쳐 방사선과 의사의 대응 범위를 확대하기 위해, 이동식 방사선 진단 장치와 클라우드 PACS, 원격 방사선 진단, 전자 건강 기록의 통합, 그리고 표준화된 DICOM·HL7 워크플로우를 결합하는 사례가 늘고 있습니다.
인공지능(AI)은 임상 전문가를 대체하는 것이 아니라, 모바일 영상 진단 워크플로우 전반에 걸쳐 누적적인 가치를 창출하고 있습니다. FDA의 승인을 받고 규제 당국의 심사를 거친 AI 기반 영상 진단 도구는 분류, 영상 품질 평가, 프로토콜 최적화, 워크플로우 우선순위 지정, 방사선 피폭량 관리, 의사결정 지원에 점점 더 많이 활용되고 있으며, 특히 흉부 영상 진단, 뇌졸중 영상 진단, 골절 감지, 유방촬영술 분야에서 그 활용이 확대되고 있습니다.
북미는 높은 진단 이용률, 공공 및 민간 분야의 폭넓은 보험 급여 체계, 장기 요양 수요, 응급 의료 대비 체계, 그리고 인증을 받은 방사선과 의료 제공업체의 대규모 기반에 힘입어 여전히 성숙한 모바일 영상 진단 서비스 시장으로 자리매김하고 있습니다. 미국은 외주형 이동식 X선, 이동식 유방촬영, 이동식 MRI, 원격 방사선 진단을 활용한 서비스 모델에서 주도적인 입지를 차지하고 있는 반면, 캐나다는 광범위하게 분산된 지역 사회 내 농촌 지역 접근성 확보, 원주민에 대한 의료 지원, 주 의료 시스템의 수용 능력 관리에 중점을 두고 있습니다.
아세안(ASEAN) 국가들에서는 섬 지역, 농촌 지역, 급성장하는 도시 지역의 인구를 아우르며, 병원, 방사선과 의사, 첨단 진단 기기의 분포가 불균형하다는 과제를 해결하기 위해 모바일 영상 진단 기술이 활용되고 있습니다. 모바일 초음파, X선, 선별 검사 서비스는 공중보건 프로그램, 민간 병원 네트워크, 1차 진료의 확대를 보완할 수 있는 지역에서 수요가 가장 높습니다.
미국은 요양 시설 내 영상 진단, 병원으로의 아웃소싱, 이동식 유방촬영술, 산업 보건 영상 진단, 원격 방사선 진단 네트워크에 힘입어 이동식 영상 진단 서비스 분야에서 가장 발전된 상업적 기반을 갖추고 있습니다. 캐나다의 요구 사항은 지방 접근성, 원주민 커뮤니티 지원, 주 차원의 역량 계획에 중점을 두고 있습니다. 한편, 멕시코와 브라질에서는 광활한 영토와 전문의의 불균형 분포라는 과제를 안고 있는 가운데, 민간 부문의 성장과 공공 부문의 접근성 문제가 공존하고 있습니다.
업계 리더는 측정 가능한 접근성 및 처리 능력 문제를 해결하는 서비스 모델을 우선시해야 합니다. 구체적으로는 환자의 전원 감소, 진단 신속화, 방사선 검사 대기 시간 해소, 선별 검사 완료율 향상, 재검사 감소, 그리고 치료의 연속성 향상 등을 들 수 있습니다. 성공적인 서비스 제공업체는 인증을 받은 기술자, 신뢰성이 높은 장비의 가동률, 최적화된 경로 설정, 방사선과 전문의에 의한 대응 체계, 방사선 안전 프로그램, 그리고 투명성이 높은 품질 지표를 종합적으로 갖추게 될 것입니다.
본 요약본은 WHO, OECD, 유엔의 인구 통계 데이터, 각국의 보건 기관, 규제 당국, 방사선 의학 전문가 단체, 진단 영상 접근성, AI를 활용한 방사선 의학, 방사선 안전, 이동형 의료 제공에 관한 동료 심사를 거친 문헌 등, 공개된 권위 있는 정보원을 바탕으로 한 2차 조사 프레임워크를 활용하여 작성되었습니다.
이동형 영상 진단 서비스는 단순한 편의성을 제공하는 서비스에서 전략적인 의료 접근 플랫폼으로 전환되고 있습니다. 가장 큰 기회는 고령화, 만성 질환 모니터링, 암 및 폐암 검진 프로그램, 지방 의료 서비스 제공, 비상사태 대비, 병원 수용 능력 관리, 장기 요양 지원, 디지털 방사선 의학의 통합과 관련되어 있습니다.
The Mobile Imaging Services Market is projected to grow by USD 4.69 billion at a CAGR of 4.75% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 3.39 billion |
| Estimated Year [2026] | USD 3.54 billion |
| Forecast Year [2032] | USD 4.69 billion |
| CAGR (%) | 4.75% |
Mobile imaging services are becoming a core access strategy for healthcare systems that need diagnostic capacity beyond fixed hospital radiology departments. The market spans mobile X-ray, ultrasound, CT, MRI, mammography, fluoroscopy, and point-of-care imaging delivered through vans, modular units, bedside systems, and on-demand staffing models.
Demand is supported by verified healthcare trends: population aging documented by the United Nations, the high global burden of noncommunicable diseases reported by the World Health Organization, and the ongoing shift toward outpatient, home-based, and long-term care. Mobile medical imaging improves reach for nursing homes, rural communities, emergency response, occupational health, sports medicine, correctional health, and hospital overflow management while supporting faster clinical decision-making.
The mobile imaging services landscape is shifting from episodic equipment deployment to integrated diagnostic networks. Providers increasingly combine mobile radiology units with cloud PACS, teleradiology, electronic health record integration, and standardized DICOM and HL7 workflows to shorten turnaround times and extend radiologist coverage across distributed care sites.
Operational models are also changing. Hospitals use mobile CT and MRI to manage peak demand, renovations, equipment downtime, and disaster response; long-term care providers rely on portable X-ray and ultrasound to reduce avoidable patient transfers; and public health programs use mobile mammography, tuberculosis screening, and lung screening to reach underserved populations. These shifts align with policy priorities around value-based care, early diagnosis, lower patient disruption, and care closer to home.
Artificial intelligence is adding cumulative value across mobile imaging workflows rather than replacing clinical professionals. FDA-cleared and regulator-reviewed AI-enabled imaging tools are increasingly used for triage, image quality assessment, protocol optimization, workflow prioritization, dose management, and decision support, especially in chest imaging, stroke imaging, fracture detection, and mammography.
For mobile imaging service providers, AI can reduce repeat scans, support consistent image acquisition, improve radiologist prioritization of urgent cases from distributed locations, and strengthen quality assurance across fleets and portable devices. Governance remains essential: AI deployment must be validated across mobile equipment types, patient populations, and care settings, with safeguards for cybersecurity, patient privacy, algorithmic bias, clinical accountability, and clinician oversight.
North America remains a mature mobile imaging services region, supported by high diagnostic utilization, broad public and private reimbursement pathways, long-term care demand, emergency medical preparedness, and a large base of accredited radiology providers. The United States leads in outsourced mobile X-ray, mobile mammography, mobile MRI, and teleradiology-enabled service models, while Canada emphasizes rural access, Indigenous health outreach, and provincial health system capacity management across widely dispersed communities.
Europe is shaped by aging populations, strong public health systems, GDPR privacy requirements, and the EU Medical Device Regulation, which influences equipment, software, and AI-enabled imaging compliance. Asia-Pacific is expanding its mobile imaging relevance as China, India, Japan, South Korea, Australia, and ASEAN markets invest in diagnostic access, cancer screening, hospital modernization, and digital health connectivity. Latin America is driven by access gaps between major cities and remote communities, with Brazil and Mexico anchoring demand through private-sector expansion and public health outreach. The Middle East benefits from healthcare infrastructure investment in GCC states, national screening initiatives, and emergency preparedness planning, while Africa's opportunity is tied to mobile diagnostics for rural access, infectious disease management, maternal care, trauma care, and limited fixed imaging capacity.
ASEAN countries are using mobile imaging to address uneven distribution of hospitals, radiologists, and advanced diagnostic equipment across island, rural, and fast-growing urban populations. Demand is strongest where mobile ultrasound, X-ray, and screening services can complement public health programs, private hospital networks, and primary care expansion.
The GCC is investing in high-acuity healthcare infrastructure and digital health platforms, making mobile CT, MRI, X-ray, ultrasound, and advanced screening services relevant for hospital expansion, national health campaigns, occupational health, and emergency preparedness. The European Union emphasizes quality standards, privacy, interoperability, and cross-border regulatory consistency under data protection and medical device rules. BRICS economies combine large patient populations with public health access challenges, creating sustained need for scalable imaging models that can serve urban hospitals and remote communities. G7 markets prioritize aging-related diagnostics, cancer screening, value-based care, workforce productivity, and AI-enabled workflow efficiency, while NATO countries increasingly view mobile medical imaging as part of health system resilience, military medicine, humanitarian response, and disaster readiness.
The United States has the most developed commercial base for mobile imaging services, supported by nursing home imaging, hospital outsourcing, mobile mammography, occupational health imaging, and teleradiology networks. Canada's needs center on rural access, Indigenous community outreach, and provincial capacity planning, while Mexico and Brazil combine private-sector growth with public-sector access challenges across large geographies and uneven specialist distribution.
In Europe, the United Kingdom uses mobile diagnostics to address waiting lists, community care, and elective recovery priorities, Germany and France emphasize quality-controlled imaging capacity and regulated clinical standards, Italy and Spain rely on mobile services for regional access and hospital workload management, and Russia's geography supports mobile screening and outreach across distant communities. China is scaling diagnostic capacity through hospital modernization, cancer screening, and digital health infrastructure; India's demand is linked to access expansion, affordability, and public-private delivery models; Japan and South Korea are shaped by advanced imaging adoption, aging populations, and strong digital healthcare ecosystems; and Australia uses mobile imaging to serve remote communities, mining regions, Indigenous health programs, and decentralized care settings.
Industry leaders should prioritize service models that solve measurable access and throughput problems: reduced patient transfers, faster diagnosis, shorter radiology backlogs, improved screening completion, fewer repeat scans, and better continuity of care. Winning providers will combine accredited technologists, reliable equipment uptime, optimized routing, radiologist coverage, radiation safety programs, and transparent quality metrics.
Executives should invest in interoperable PACS/RIS connectivity, secure cloud workflows, cybersecurity controls, AI-assisted workflow tools, and evidence-based clinical protocols aligned with ACR, ESR, IAEA, WHO, and local regulatory guidance. Partnerships with hospitals, long-term care networks, employers, public health agencies, emergency services, and payers can strengthen utilization and clinical impact. Providers should also build workforce pipelines for radiographers, sonographers, drivers, biomedical engineers, dispatch coordinators, and remote radiologists while documenting outcomes that matter to health systems.
This executive summary is developed using a secondary research framework grounded in publicly available, authoritative sources including WHO, OECD, United Nations demographic data, national health agencies, regulatory authorities, professional radiology associations, and peer-reviewed literature on diagnostic imaging access, AI-enabled radiology, radiation safety, and mobile care delivery.
The methodology emphasizes triangulation across clinical guidelines, reimbursement patterns, technology adoption, regional healthcare infrastructure, workforce constraints, regulatory requirements, and macro-demographic indicators. Insights avoid unsupported market-size claims and focus on verified demand drivers, compliance realities, operational constraints, and strategic implications for mobile imaging service providers.
Mobile imaging services are moving from a convenience offering to a strategic healthcare access platform. The strongest opportunities are tied to aging populations, chronic disease monitoring, cancer and lung screening programs, rural care delivery, emergency preparedness, hospital capacity management, long-term care support, and digital radiology integration.
Providers that combine clinical quality, operational discipline, AI-enabled workflow, data security, regulatory compliance, and payer-aligned outcomes will be best positioned. As diagnostic imaging demand rises across hospitals and community-based care settings, mobile imaging services can help health systems deliver earlier diagnosis, reduce unnecessary transfers, and expand equitable access to essential medical imaging.